This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 6–8, 2023 | Munich, GermanyNovember 14–15, 2023 | Digital Partnering

PreComb Therapeutics AG


PreComb is building a clinical drug efficacy testing platform based on its 3DTwin® technology for ex vivo drug testing on primary patient tumors. Our clinical partners are equipped with PreComb’s 3DTwin® technology for automated and standardized drug testing directly on site. This allows pharma/biotech to test new drugs/combinations on cohorts of tumor twins derived from native tumor tissue in a physiological and cost-efficient manner. We provide clinical evidence for new cancer therapies to increase developmental success rates.